Skip to main content

Persistent Asset Partners Ltd

Position in PCVX — Vaxcyte, Inc.

CIK 2056052 HONG KONG, K3

Position in PCVX

as of Jun 30, 2026 · filed Aug 7, 2026
Position Value
$878,053
+$568,966 QoQ
Shares Held
15,105
+184.0% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
0.29%
of 13F equity value
Holder Rank
#167
of 329 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in PCVX Over Time

Shares Held

Position Value (USD)

Derivatives in PCVX

reported options exposure · as of Jun 30, 2026
CallValue
$7,847
CallShares
135
PutValue
$7,266
PutShares
125

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Persistent Asset Partners Ltd holds $74,585,923 across 142 Biotechnology names. PCVX ranks #16 (1.2% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in PCVX

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $7,266 125
2026-06-30 $7,847 135
2026-06-30 $878,053 15,105
2026-03-31 $309,087 5,319
2026-03-31 $7,844 135
2025-12-31 $246,110 5,334
2025-09-30 $1,803,737 50,076
2025-06-30 $1,479,172 45,499
2025-03-31 $798,208 21,139
2024-12-31 $1,567,700 19,151